Medical Device company Motus GI sets terms for $30 million IPO

Motus GI Holdings, which is developing a medical device to assist with intraprocedural colonoscopy cleaning, announced terms for its IPO on Wednesday.

The Tirat Carmel, Israel-based company plans to raise $30 million by offering 4.3 million shares at a price range of $6 to $8. At the midpoint of the proposed range, Motus GI Holdings would command a fully diluted market value of $121 million.

Motus GI Holdings was founded in 2008 and plans to list on the Nasdaq under the symbol MOTS. Piper Jaffray and Oppenheimer & Co. are the joint bookrunners on the deal. It is expected to price during the week of February 5, 2018.

The article Medical device company Motus GI sets terms for $30 million IPO originally appeared on IPO investment manager Renaissance Capital’s web site renaissancecapital.com.

Medical Device company Motus GI sets terms for $30 million IPO

WATCH THE PURE-VU SYSTEM

For more information, please visit: Motus GI & the “Pure-Vu system”

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close